PC 945

Drug Profile

PC 945

Alternative Names: PC945

Latest Information Update: 02 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pulmocide
  • Class Antifungals; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Aspergillosis

Most Recent Events

  • 23 Oct 2017 Phase-I clinical trials in Aspergillosis (In volunteers) in United Kingdom (Inhalation) (NCT02715570)
  • 26 Oct 2016 Interim pharmacodynamics data from a preclinical study in Aspergillosis released by Pulmocide
  • 30 Mar 2016 Preclinical trials in Aspergillosis in United Kingdom (Inhalation) before March 2016 (Pulmocide Pipeline, March 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top